These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26813689)

  • 1. [Gynecological cancers in patients with inflammatory rheumatic diseases].
    Schmalzing M; Krockenberger M; Honig A; Tony HP
    Z Rheumatol; 2016 Feb; 75(1):63-7. PubMed ID: 26813689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genitourinary malignancies and rheumatoid arthritis].
    Boegemann M; Alten R; Aringer M; Zastrow S
    Z Rheumatol; 2016 Feb; 75(1):54-62. PubMed ID: 26786167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus.
    Ramos PC; Mendez MJ; Ames PR; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1996; 14(3):295-9. PubMed ID: 8809444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of cardiovascular risk factors].
    Krüger K
    Z Rheumatol; 2016 Mar; 75(2):173-80; quiz 181-2. PubMed ID: 26924198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biologics].
    Kalden JR
    Z Rheumatol; 2016 Aug; 75(6):604-10. PubMed ID: 27365024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in treatment of systemic lupus erythematosus].
    Wang Q; Zhang X
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):161-4. PubMed ID: 23751573
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety of Intravenous Cyclophosphamide in the Treatment of Rheumatic Diseases.
    Woytala PJ; Morgiel E; Łuczak A; Czesak-Woytala K; Wiland P
    Adv Clin Exp Med; 2016; 25(3):479-84. PubMed ID: 27629736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal manifestations of rheumatological disorders.
    Biswas S; Paul R
    J Indian Med Assoc; 2013 Aug; 111(8):542-4, 552. PubMed ID: 24783393
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased risk of malignancy in patients with systemic lupus erythematosus.
    Ramsey-Goldman R; Mattai SA; Schilling E; Chiu YL; Alo CJ; Howe HL; Manzi S
    J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The occurrence of malignancies in a Hungarian lupus population].
    Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B; Cikes N
    Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus and malignancies.
    Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
    Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report.
    Abdel Galil SM
    Lupus; 2015 May; 24(6):638-40. PubMed ID: 25424894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations on the use of rituximab for ANCA-associated vasculitis].
    Gause AM; Rubbert-Roth A;
    Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for risk of cardiomyopathy with hydroxychloroquine.
    Sumpter MD; Tatro LS; Stoecker WV; Rader RK
    Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
    [No Abstract]   [Full Text] [Related]  

  • 19. Pneumocystis carinii pneumonia after discontinuation of hydroxychloroquine in 2 patients with systemic lupus erythematosus.
    Podrebarac TA; Jovaisas A; Karsh J
    J Rheumatol; 1996 Jan; 23(1):199-200. PubMed ID: 8838542
    [No Abstract]   [Full Text] [Related]  

  • 20. Underestimation of the efficacy, effectiveness, tolerability, and safety of weekly low-dose methotrexate in information presented to physicians and patients.
    Pincus T; Furer V; Sokka T
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S68-79. PubMed ID: 21044437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.